---
title: "Anteris Technologies Secures Favorable ATO Tax Rulings"
date: "2025-02-13 14:52:10"
summary: "Maximize Your Portfolio with Data Driven Insights:Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions. Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart PortfolioAnteris Technologies ( (AU:AVR) ) just..."
categories:
  - "tipranks_announcements"
lang:
  - "en"
translations:
  - "en"
tags:
  - "tipranks_announcements"
menu: ""
thumbnail: "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1264051801-750x406.jpg"
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

### Maximize Your Portfolio with Data Driven Insights:

* Leverage the power of [TipRanks' Smart Score](https://www.tipranks.com/screener/top-smart-score-stocks), a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
* Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with  [Your Smart Portfolio](https://www.tipranks.com/smart-portfolio/holdings)

Anteris Technologies ( [(AU:AVR)](https://www.tipranks.com/stocks/au:avr) ) just unveiled an update.

Anteris Technologies announced that the Australian Taxation Office has issued favorable class rulings regarding rollover relief for shareholders and optionholders in relation to Australian capital gains tax. This development, following the implementation of Schemes of Arrangement, is significant for stakeholders as it provides tax clarity and potentially enhances shareholder value.

**More about Anteris Technologies**

Anteris Technologies Global Corp. is a global structural heart company focused on designing, developing, and commercializing advanced medical devices to restore healthy heart function. Originating in Australia with a strong presence in Minneapolis, USA, Anteris is known for its science-driven approach and its lead product, the DurAVR® Transcatheter Heart Valve (THV), which addresses aortic stenosis using biomimetic and anti-calcification technology.

**Average Trading Volume:** 3,501

**Technical Sentiment Consensus Rating:** Buy

**Current Market Cap:** $175.7M

Learn more about AVR stock on [TipRanks’ Stock Analysis page](https://www.tipranks.com/stocks/au:avr/stock-analysis).

Trending Articles:
------------------

* [Amazon and Google-Backed Anthropic Says Revenue Could Reach $34.5B in 2027](https://www.tipranks.com/news/amazon-and-google-backed-anthropic-says-revenue-could-reach-34-5b-in-2027)
* [‘This Is a No-Go Zone,’ Says Investor About Palantir Stock](https://www.tipranks.com/news/this-is-a-no-go-zone-says-investor-about-palantir-stock)
* [‘No Need to Rush In,’ Says Oppenheimer About Tesla Stock](https://www.tipranks.com/news/no-need-to-rush-in-says-oppenheimer-about-tesla-stock)

[tipranks_announcements](https://www.tipranks.com/news/company-announcements/anteris-technologies-secures-favorable-ato-tax-rulings)
